Pilot double-blind randomized placebo-controlled study of memantine and restricted language therapy in post-stroke aphasia

Phase 4, randomised, double-blind trial in aphasia comparing Memantine + restricted language therapy with Placebo + restricted language therapy (2 arms). Primary endpoints: Neurophysiological changes measured by cognitive evoked potentials and Language recovery in post-stroke aphasia. Started Apr 2006; status: active.